GNH USA

Europe — EMA

Moxonidine Viatris

GNH USA supplies Moxonidine Viatris (Moxonidine), an imidazoline receptor agonist indicated for hypertension management.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxonidine Viatris, is an imidazoline receptor agonist presented as an oral tablet for oral use. It is employed to lower elevated blood pressure in adult patients with hypertension, offering an alternative mechanism to traditional vasodilators.

GNH USA supplies Moxonidine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet the needs of healthcare providers across multiple global continents.

What is Moxonidine used for?

Moxonidine acts on central imidazoline I1 receptors to reduce sympathetic outflow, making it useful in hypertension management.

Primary hypertension: reduces systemic blood pressure in patients with essential hypertension. Essential hypertension: helps achieve target blood pressure levels. Resistant hypertension: provides additional control when other antihypertensives are insufficient.

What are the side effects of Moxonidine?

Moxonidine may be associated with several adverse reactions, which are categorized by frequency.

Common Side Effects: - Dry mouth: persistent sensation of oral dryness that may affect swallowing. - Drowsiness: mild sleepiness or fatigue that can occur during the day. - Headache: mild to moderate head pain, often relieved with simple analgesics. - Dizziness: feeling of light‑headedness, especially upon standing quickly. - Nausea: upset stomach or urge to vomit, usually transient. - Fatigue: persistent lack of energy that may interfere with daily activities.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting or syncope. - Allergic reactions: rash, itching, swelling, or anaphylaxis in susceptible individuals. - Liver enzyme elevation: increased ALT/AST levels indicating possible hepatic stress. - Heart block: abnormal cardiac conduction that may require medical attention.

What precautions apply to Moxonidine?

Before initiating therapy, clinicians should consider several safety factors.

Renal impairment: monitor kidney function and adjust therapy as needed. Hepatic dysfunction: use with caution; liver enzymes should be checked periodically. Elderly patients: increased sensitivity to blood pressure lowering; start at low dose. Concomitant antihypertensives: risk of additive hypotension; observe blood pressure closely. Pregnancy and lactation: safety not established; avoid unless benefit outweighs risk. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

What does Moxonidine interact with?

Moxonidine can interact with other medicines, requiring attention to combination therapy.

Major Interactions (Avoid): - Combined use with other central antihypertensives (e.g., clonidine, guanfacine): may cause severe hypotension. - Co‑administration with strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): can increase plasma concentrations of moxonidine.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may attenuate antihypertensive effect. - Diuretics: additive blood pressure lowering; monitor for orthostatic symptoms. - Beta‑blockers: potential for enhanced hypotensive response; observe patient.

Frequently asked questions

What is Moxonidine Viatris used for?+
Moxonidine Viatris is prescribed to lower elevated blood pressure in adults with hypertension. By acting on central nervous system pathways, it helps achieve target blood pressure levels, especially in patients who need an alternative to traditional vasodilators or who have resistant hypertension.
How does moxonidine work?+
Moxonidine selectively activates imidazoline I1 receptors in the brainstem, which reduces sympathetic nervous system outflow. This leads to decreased peripheral vascular resistance and a modest reduction in cardiac output, together resulting in lower arterial blood pressure without directly blocking adrenergic receptors.
What is the usual dose of Moxonidine Viatris?+
The dosage of Moxonidine Viatris is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.
Is Moxonidine Viatris safe during pregnancy or breastfeeding?+
Safety data for moxonidine in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should be avoided during pregnancy and breastfeeding unless the potential benefit justifies the potential risk, and only under close medical supervision.
How do I order Moxonidine Viatris from GNH USA?+
To request Moxonidine Viatris, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does moxonidine compare with other antihypertensive classes?+
Moxonidine offers a distinct mechanism by targeting central imidazoline I1 receptors, unlike β‑blockers, ACE inhibitors or calcium‑channel blockers that act peripherally. This can be advantageous in patients who experience side effects from other classes or who need additional blood‑pressure control in resistant hypertension.
How should Moxonidine Viatris be stored and handled?+
Store the product at ambient temperature, preferably below 25 °C, in its original container. Protect it from moisture, direct sunlight and extreme heat. Keep the packaging tightly closed and out of reach of children to maintain product integrity.
How is Moxonidine Viatris administered?+
Moxonidine Viatris is taken orally, usually as a tablet, with or without food as directed by the prescriber. The medication should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.
What are the most serious risks associated with Moxonidine Viatris?+
The most serious adverse events include severe hypotension, which can cause fainting, and rare allergic reactions such as rash, swelling or anaphylaxis. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, or signs of a severe allergic response.
Who should not use Moxonidine Viatris?+
Moxonidine is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. It should also be avoided in patients with severe renal or hepatic impairment where safety has not been established, and in pregnant or breastfeeding women unless the benefit outweighs the risk.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Viatris Sante
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU